Tumor Endothelial Cells Acquire Drug Resistance by MDR1 Up-Regulation via VEGF Signaling in Tumor Microenvironment

Akiyama, Kosuke, Ohga, Noritaka, Hida, Yasuhiro, Kawamoto, Taisuke, Sadamoto, Yoshihiro, Ishikawa, Shuhei, Maishi, Nako, Akino, Tomoshige +5 more·2012·The American Journal of Pathology
DOI 10.1016/j.ajpath.2011.11.029

Cited by (155)

Items 101–155 of 155

  1. Development of Immortalized Human Tumor Endothelial Cells from Renal Cancer
    Nako Maishi, Hiroshi Kikuchi, Masumi Sato, Hiroko Nagao‐Kitamoto, Dorcas A. Annan, Shogo Baba, T. Hojo, Misa Yanagiya, Yusuke Ohba, Genichiro Ishii et al. · 2019 · International Journal of Molecular Sciences
  2. Prokineticin 1 expression in gastrointestinal tumors.
    Takanori Goi, Toshiyuki Nakazawa, Yasuo Hirono, Akio Yamaguchi · 2013 · PubMed
  3. Research advances of secretory proteins in malignant tumors
    Na Zhang, Jia‐Jie Hao, Yan Cai, Ming‐Rong Wang · 2021 · Chinese Journal of Cancer Research
  4. Human breast tumor derived endothelial cells exhibit distinct biological properties
    Mangala Hegde, Sharath Mohan Bhat, Kanive Parashiva Guruprasad, Rajasekhar Moka, Lingadakai Ramachandra, Kapaettu Satyamoorthy, Manjunath Bandu Joshi · 2021 · Biology of the Cell
  5. Tumor endothelial cells express high pentraxin 3 levels
    Kyoko Hida, Nako Maishi, Taisuke Kawamoto, Kosuke Akiyama, Noritaka Ohga, Yasuhiro Hida, Kenji Yamada, T. Hojo, Hiroshi Kikuchi, Masumi Sato et al. · 2016 · Pathology International
  6. Correlation between endothelial CXCR7 expression and clinicopathological factors in oral squamous cell carcinoma
    Misa Yanagiya, Randa Dawood, Nako Maishi, Yasuhiro Hida, Chisaho Torii, Dorcas A. Annan, Hiroshi Kikuchi, Aya Matsuda, Tetsuya Kitamura, Yoichi Ohiro et al. · 2021 · Pathology International
  7. Synthetic paclitaxel-octreotide conjugate reversing the resistance of A2780/Taxol to paclitaxel in xenografted tumor in nude mice
    Xi Chen, Xiao-Yu Zhang, Yang Shen, Lili Fan, Mulan Ren, Yong-Ping Wu · 2016 · Oncotarget
  8. Synthetic paclitaxel-octreotide conjugate reverses the resistance of paclitaxel in A2780/Taxol ovarian cancer cell line
    Yang Shen, Xiao-Yu Zhang, Xi Chen, Lili Fan, Mulan Ren, Yong-Ping Wu, Kenneth Chanda, Shi‐Wen Jiang · 2016 · Oncology Reports
  9. The Secretome Engages STAT3 to Favor a Cytokine-rich Microenvironment in Mediating Acquired Resistance to FGFR Inhibitors
    Xinyi Wang, Jing Ai, Hongyan Liu, Peng Xia, Hui Chen, Yi Chen, Yi Su, Aijun Shen, Xun Huang, Jian Ding et al. · 2018 · Molecular Cancer Therapeutics
  10. Low-dose metronomic cisplatin as an antiangiogenic and anti-inflammatory strategy for cancer
    Hiroshi Kikuchi, Nako Maishi, Li Yu, Zi Jia, Cong Li, Masumi Sato, Ryo Takeda, Keita Ishizuka, Yasuhiro Hida, Nobuo Shinohara et al. · 2023 · British Journal of Cancer
  11. Integrative Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unveils the Characteristics of the Immune Microenvironment and Prognosis Signature in Prostate Cancer
    Ruisong Wang, Yaqian Xiao, Meisen Pan, Zhongyuan Chen, Pinhong Yang · 2022 · Journal of Oncology
  12. Effects of toceranib phosphate (Palladia) monotherapy on multidrug resistant lymphoma in dogs
    Hiroki Yamazaki, Naoki Miura, Yu‐Chang Lai, Masashi Takahashi, Yuko Goto‐Koshino, Yasuyuki Momoi, Munekazu NAKAICHI, Hajime Tsujimoto, Asuka Setoguchi, Yasuyuki Endo · 2017 · Journal of Veterinary Medical Science
  13. Metronomic chemotherapy in hematology: Lessons from preclinical and clinical studies to build a solid rationale for future schedules
    Marta Banchi, Maria Christina Cox, Guido Bocci · 2024 · Cancer Letters
  14. Down-regulation of MDR1 by Ad-DKK3 via Akt/NFκB pathways augments the anti-tumor effect of temozolomide in glioblastoma cells and a murine xenograft model
    Toshitaka Fujihara, Yoshifumi Mizobuchi, Kohei Nakajima, Teruyoshi Kageji, Kazuhito Matsuzaki, Keiko T. Kitazato, Ryotaro Otsuka, Keijiro Hara, Hideo Mure, Toshiyuki Okazaki et al. · 2018 · Journal of Neuro-Oncology
  15. Selenium nanoparticles restrain recurrence of cervical cancer in drug-free period by inhibiting the expression of ABC transporters
    Ting Liu, Shuya Pan, Qingfeng Zhou, Ziyi Yang, Zihan Zhang, Hejing Liu, Li-Zhen He, Jingyuan Lan, Ying Hua, Tianfeng Chen et al. · 2025 · Nano Today
  16. Exploring the role of endothelium in the tumour response to anti-angiogenic therapy
    Michael Y. He, Michael M. Halford, Marc G. Achen, Steven A. Stacker · 2014 · Biochemical Society Transactions
  17. Cross-drug resistance to sunitinib induced by doxorubicin in endothelial cells
    Limin Huang, Chaoquan Hu, Mélanie Di Benedetto, Rémi Varin, Jielin Liu, Jian Jun Jin, Li Wang, Jean‐Pierre Vannier, Anne Janin, Lu H et al. · 2014 · Oncology Letters
  18. The functional network of biglycan: A new frontier in tumor progression
    Li Yu, Nako Maishi, Aya Matsuda, Kyoko Hida · 2023 · Proteoglycan Research
  19. Isolation of tumor endothelial cells from murine cancer
    Kazuhiro Taguchi, Takashi Onoe, Tomoaki Yoshida, Yoshinori Yamashita, Kiyomi Taniyama, Hideki Ohdan · 2018 · Journal of Immunological Methods
  20. JMJD6-driven epigenetic activation of COL4A2 reprograms glioblastoma vascularization via integrin α1β1-dependent PI3K/MAPK signaling
    Yangyang Wu, Yanan Wu, Shuchou Xia, Hongkai Lian, Yongli Lou, Lin-Jian Wang · 2025 · Acta Neuropathologica Communications
  21. Improving therapeutic resistance: beginning with targeting the tumor microenvironment
    Xiaoying Guan, Xiaoli Guan, Zuoyi Jiao · 2021 · Journal of Chemotherapy
  22. Research progress of siVEGF complex and their application in antiangiogenic therapy
    Yan Wang, Yingying Wei, Lin Chen, Yongzhen Yang, Jia Fan, Weiran Yu, Shizhao Zhou, Shiping Yu · 2023 · International Journal of Pharmaceutics
  23. BFGF neutralization stimulates VEGF secretion in melanoma B16 cells
    Zhiyong Wang, Wei Pei, Junjian Xiang, Hong Wang · 2017 · Cytokine
  24. Resistance of melanoma cells to anticancer treatment: a role of vascular endothelial growth factor
    Joanna Bogusławska-Duch, Magdalena Ducher, Maciej Małecki · 2020 · Advances in Dermatology and Allergology
  25. Nanomodulation and nanotherapeutics of tumor-microenvironment
    Rupal Dubey, Sourbh Suren Garg, Jeena Gupta · 2022 · OpenNano
  26. Isolation and characterization of canine tumor endothelial cells
    Yusuke IZUMI, Yuki Hoshino, Kenji Hosoya, Satoshi Takagi, Masahiro Okumura · 2014 · Journal of Veterinary Medical Science
  27. Tumor Blood Vessels as Targets for Cancer Therapy
    Kyoko Hida, Nako Maishi, Yasuhiro Hida · 2019 · Springer eBooks
  28. Mechanisms and intervention strategies of microenvironment-mediated drug resistance in multiple myeloma
    Zhu Xiaoling, Chen Qi, Yan Tingting, He Di, Yu Meijia · 2026 · Cancer Cell International
  29. CopA3 treatment suppressed multidrug resistivity in HCT-116 cell line by p53-induced degradation of hypoxia-inducible factor 1α
    Debasish Kumar Dey, Himanshi Gahlot, Sukkum Ngullie Chang, Sun Chul Kang · 2023 · Life Sciences
  30. Anti-angiogenic Cancer Therapy: Development of Resistance
    Doménico Ribatti · 2019 · Springer eBooks
  31. Association of PKCi variant and its gene expression with breast cancer prognosis
    Hania Shah, Khushbukhat Khan, Yasmin Badshah, Janeen H. Trembley, Naeem Mahmood Ashraf, Maria Shabbir, Tayyaba Afsar, Ali Madi Almajwal, Suhail Razak · 2022 · Research Square
  32. Apatinib reduces liver cancer cell multidrug resistance by modulating NF-κB signaling pathway
    XIAOXIAO HE, XUEQING ZHOU, J. Zhang, MINGFEI ZHANG, DANHONG ZENG, Heng Zhang, SHUCAI YANG · 2024 · Biocell
  33. Paracrine signalling in breast cancer: Insights into the tumour endothelial phenotype
    Atarah Rass, Carla Eksteen, Anna‐Mart Engelbrecht · 2024 · Acta Histochemica
  34. Unravelling the role of PRKCI and key-cancer related genes in breast cancer development and metastasis
    Hania Shah, Khushbukhat Khan, Yasmin Badshah, Janeen H. Trembley, Naeem Mahmood Ashraf, Maria Shabbir, Tayyaba Afsar, Dara A. Aldisi, Dilawer Khan, Suhail Razak · 2025 · Discover Oncology
  35. Chaperone-mediated autophagy controlling VEGFR1 degradation contributes cross talk between breast cancer cells and endothelial cells triggering tumorigenesis via the VEGF-VEGFR2 axis
    Sha Chen, Xiang Li, Meng He, Qi Han, Yang Zhang, Mingzhen Yang, An Chen, Jiqin Lian, Shuhui Li · 2025 · Oncogene
  36. Tumor endothelial cells revisited: Their crucial role in tumor progression
    Doménico Ribatti · 2026 · Tissue and Cell
  37. An in vitro assessment of surface modification strategies for orthopedic applications
    Chye Khoon Poh, Yanli Cai, Xiao Wei Tan, Hark Chuan Tan, Wilson Wang · 2013 · Thin Solid Films
  38. Abnormality of tumor endothelial cells and cancer progression
    Kyoko Hida, Kosuke Akiyama, Noritaka Ohga, Nako Maishi · 2012 · Journal of Japanese Society of Oral Oncology
  39. The Tumor Microenvironment
    Thomson Santosh Alex, Damanpreet Kaur Lang, Foziyah Zakir, Aamir Mirza, Zeenat Iqbal · 2022 · Environmental chemistry for a sustainable world
  40. Hsa-miR-548k blocks the drug resistance cascade in NSCLC cancer by targeting the key genes involved in various chemotherapy resistance pathways
    Zahra Ghasemi, Sayedeh Azimeh Hosseini, Hajar Yaghoobi · 2023 · Human Gene
  41. Anti-Angiogenic Cancer Therapy: Development of Resistance
    Doménico Ribatti · 2017 · Springer eBooks
  42. Targeting the Colchicine Binding Site on Tubulin to Overcome Multidrug Resistance and Anticancer Efficacy of Selective Survivin Inhibitors
    Kinsle Arnst · 2018
  43. Endothelial Cells Promote Docetaxel Resistance of Prostate Cancer via FGF2/ERG/Akt/mTOR Signaling Pathway
    Wenhao Zhou, Yiming Su, Yu Zhang, Bangmin Han, Haitao Liu, Xiaohai Wang · 2020
  44. Epigenetic Control of Genes Involved in Cancer Initiation and Progression
    Sabita N. Saldanha, Shivani Soni · 2016 · Springer eBooks
  45. Tumor Blood Vessels and Tumor Endothelial Cells
    Doménico Ribatti · 2016 · Springer eBooks
  46. Original Article Prognostic role of YB-1 expression in breast cancer: a meta-analysis
    Xu Wang, Xiaobo Guo, Xiaochun Shen, Hao Zhou, Dan-Wei Wan, Xiaofeng Xue, Ye Han, Bin Yuan, Jin Zhou, Hong Zhao et al. · 2015
  47. Translational Study of Liver Cancer and Hypertrophy: TranSLiCH
    Tun Abraham, Mauro Enrique · 2016 · Scholarship@Western (Western University)
  48. The characteristics of tumor endothelial cells
    Kyoko Hida · 2018 · Journal of The Society of Japanese Women Scientists
  49. Tumor blood vessels and tumor endothelial cells
    Doménico Ribatti · 2021 · Elsevier eBooks
  50. The endothelial cells in cancer: an outline
    Doménico Ribatti, Francesco Pezzella · 2022 · Elsevier eBooks
  51. EGF-induced P-gp expression in tumor vasculature contributes to therapeutic resistance to doxorubicin-PEG-liposomes in mice bearing doxorubicin-resistant B16-BL6 tumors
    Masato Maruyama, Tomoki Ueda, Yusuke Ienaka, Haruka Tojo, Kenji Hyodo, Ken‐ichi Ogawara, Kazutaka Higaki · 2025 · Journal of Drug Delivery Science and Technology
  52. Additional file 1 of Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation
    Quan, Lili, Ryuichi Ohgaki, Saori Hara, Okuda, Suguru, Wei, Ling, Hiroki Okanishi, Nagamori, Shushi, Hitoshi Endou, Kanai, Yoshikatsu · 2020 · Figshare
  53. Le rôle de deux alarmines extracellulaires, HMGB1 et l’ATP, dans le cadre du cancer colorectal
    Clémentine Dillard · 2021
  54. Le rôle des plaquettes dans la formation du microenvironnement tumoral
    Ophélie Le Chapelain · 2023
  55. BindingDB Entry 50046810: Hybrids from 4-anilinoquinazoline and hydroxamic acid as dual inhibitors of vascular endothelial growth factor receptor-2 and histone deacetylase.
    BindingDB · 2016 · UC San Diego